Skip to main content

Table 1 Clinical and tumor characteristics of the LUAD cohorts

From: Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma

 

TCGA cohort

GEO cohort

No. of patients

316

381

Age (median, range)

64 (33–86)

69 (38–89)

Gender

 Female

163 (51.6%)

166 (43.6%)

 Male

153 (48.4%)

215 (56.4%)

Tumor

 T 1–2

275 (87.0%)

NA

 T 3–4

41 (13.0%)

NA

Node

N 0–1

267 (84.5%)

NA

N 2–3

49 (15.5%)

NA

Metastasis

M 0

296 (93.7%)

NA

M 1

20 (6.3%)

NA

TNM stage

 I

164 (51.9%)

246 (64.6%)

 II

76 (24.1%)

65 (17.1%)

 III

56 (17.7%)

56 (14.7%)

 IV

20 (6.3%)

14 (3.6%)

TP53

 Wide type

NA

287 (75.3%)

 Mutant type

NA

94 (24.7%)

Survival status

 OS years (median)

2.19

2.24

  1. LUAD adenocarcinoma of lung, TCGA The Cancer Genome Atlas, GEO Gene Expression Omnibus, No number, T tumor, N regional lymph node, M metastasis, NA not available, OS overall survival